Latest Breaking News On - Prnewswire brainstorm cell therapeutics inc - Page 1 : comparemela.com

BrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwn

The data will be presented at the Annual ALS Drug Development Summit, which is focused on identifying transformative ALS targets, seeking translational biomarkers and propelling more clinical.

United statesClene nanomedicineAntonio trejoMarjan sepassiAngela gengeMary kay turnerStacy lindborgMichael woodChristopher ocampoLisa guitermanNational ms societyAccess programNurown programGlobal patient advocacy public affairsEuropean medicines agencyCalifornia institute for regenerative medicine

Brainstorm Cell Therapeutics Announces First Quarter 2024 Financial Results And Provides Corporate Update

Brainstorm Cell Therapeutics Announces First Quarter 2024 Financial Results And Provides Corporate Update
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesDebamestrocel nurownAntonio trejoMichael woodChaim lebovitsKylan morrisStacy lindborgBob dagherMary kay turnerDrug development summitDrug administrationMenafn pr newswire companyNurown programPrnewswire brainstorm cell therapeutics incNational ms societyGlobal patient advocacy public affairs

BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule

NEW YORK, April 11, 2024 /PRNewswire/ BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, today announced that it received a notification.

United statesMichael woodPrnewswire brainstorm cell therapeutics incNational ms societyBrainstorm cell therapeutics incEuropean medicines agencyListing qualifications departmentDrug administrationCalifornia institute for regenerative medicineStorm cell therapeuticsNasdaq stock marketNasdaq listing ruleNotification letterOrphan drugCalifornia instituteRegenerative medicine

BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn s® Phase 3 Clinical Trial in ALS

BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn s® Phase 3 Clinical Trial in ALS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University of california irvineUnited statesUniversity of massachusettsLisa guitermanAnthonyj windebankStacy lindborgRobertj manningMichael woodJulieanne doranJean pape adamsChaim lebovitsRobert brownCalifornia pacific medical centerCalifornia institute for regenerative medicineNational ms societyBrainstorm cell therapeutics inc

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesLisa guitermanChaim lebovitsStacy lindborgMichael woodCalifornia institute for regenerative medicinePrnewswire brainstorm cell therapeutics incNational ms societyDrug administrationData monitoring committeeEuropean medicines agencyBrainstorm cell therapeutics incStorm cell therapeuticsSpecial protocol assessmentBiologics license applicationChief executive officer